Jun 03,2021 01:56 PM
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectru... More
Reports by sun-pharmaceuticals-industries-ltd-share-price
Jun 22, 2021 08:23 AM
The company’s consolidated revenue stood at Rs8,259.30cr, up 15.7% yoy and 17.2% qoq.
27 May 2021
10 May 2021
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the... More
16 Mar 2021
05 Feb 2021
COM 16/03/2021Please find enclosed respective Notices of NCLT Convened Meeting of equity shareholder... More
29 Jan 2021
09 Feb 2021
The Board at its meeting held today, declared an interim dividend of Rs. 5.50/- (Rupees Five and pai... More